261 related articles for article (PubMed ID: 33923900)
1. Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research.
Pandey M; Choudhury H; Binti Abd Aziz A; Bhattamisra SK; Gorain B; Su JST; Tan CL; Chin WY; Yip KY
Polymers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923900
[TBL] [Abstract][Full Text] [Related]
2. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate.
Gupta S; Vyas SP
Sci Pharm; 2010; 78(4):959-76. PubMed ID: 21179328
[TBL] [Abstract][Full Text] [Related]
3. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
[TBL] [Abstract][Full Text] [Related]
4. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles laden in situ gelling system for ocular drug targeting.
Kumar D; Jain N; Gulati N; Nagaich U
J Adv Pharm Technol Res; 2013 Jan; 4(1):9-17. PubMed ID: 23662277
[TBL] [Abstract][Full Text] [Related]
6. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route.
Chowhan A; Giri TK
Int J Biol Macromol; 2020 May; 150():559-572. PubMed ID: 32057864
[TBL] [Abstract][Full Text] [Related]
7. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
8. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
9. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
10. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
11. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
Srividya B; Cardoza RM; Amin PD
J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
[TBL] [Abstract][Full Text] [Related]
12. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.
Irimia T; Dinu-Pîrvu CE; Ghica MV; Lupuleasa D; Muntean DL; Udeanu DI; Popa L
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30304825
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride.
Nanjwade BK; Deshmukh RV; Gaikwad KR; Parikh KA; Manvi FV
Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):117-23. PubMed ID: 22015966
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride.
Makwana SB; Patel VA; Parmar SJ
Results Pharma Sci; 2016; 6():1-6. PubMed ID: 26949596
[TBL] [Abstract][Full Text] [Related]
16. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
Agrawal AK; Das M; Jain S
Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
Gupta S; Samanta MK
Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
[TBL] [Abstract][Full Text] [Related]
18. An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Pharm Bioallied Sci; 2015; 7(1):9-14. PubMed ID: 25709330
[TBL] [Abstract][Full Text] [Related]
19. Design, Characterization and Pharmacokinetic-Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma.
Rawat PS; Ravi PR; Mir SI; Khan MS; Kathuria H; Katnapally P; Bhatnagar U
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839727
[TBL] [Abstract][Full Text] [Related]
20. In-situ gel: A smart carrier for drug delivery.
Garg A; Agrawal R; Singh Chauhan C; Deshmukh R
Int J Pharm; 2024 Mar; 652():123819. PubMed ID: 38242256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
